TPG Buys Par Pharmaceuticals for $1.9B, Spiking PRX Stock

Par Pharmaceuticals (PRX) of Woodcliff Lake, N.J., announced early Monday that that it has agreed to be purchased by private investment firm TPG for $1.9 billion, or $50 per share...

Keep Reading →